Gobbi, S.; Martini, S.; Rozza, R.; Spinello, A.; Caciolla, J.; Rampa, A.; Belluti, F.; Zaffaroni, N.; Magistrato, A.; Bisi, A.
Switching from Aromatase Inhibitors to Dual Targeting Flavonoid-Based Compounds for Breast Cancer Treatment. Molecules 2023, 28, 3047.
https://doi.org/10.3390/molecules28073047
AMA Style
Gobbi S, Martini S, Rozza R, Spinello A, Caciolla J, Rampa A, Belluti F, Zaffaroni N, Magistrato A, Bisi A.
Switching from Aromatase Inhibitors to Dual Targeting Flavonoid-Based Compounds for Breast Cancer Treatment. Molecules. 2023; 28(7):3047.
https://doi.org/10.3390/molecules28073047
Chicago/Turabian Style
Gobbi, Silvia, Silvia Martini, Riccardo Rozza, Angelo Spinello, Jessica Caciolla, Angela Rampa, Federica Belluti, Nadia Zaffaroni, Alessandra Magistrato, and Alessandra Bisi.
2023. "Switching from Aromatase Inhibitors to Dual Targeting Flavonoid-Based Compounds for Breast Cancer Treatment" Molecules 28, no. 7: 3047.
https://doi.org/10.3390/molecules28073047
APA Style
Gobbi, S., Martini, S., Rozza, R., Spinello, A., Caciolla, J., Rampa, A., Belluti, F., Zaffaroni, N., Magistrato, A., & Bisi, A.
(2023). Switching from Aromatase Inhibitors to Dual Targeting Flavonoid-Based Compounds for Breast Cancer Treatment. Molecules, 28(7), 3047.
https://doi.org/10.3390/molecules28073047